KRMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
KRMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
KORU Medical Systems's book value per share for the quarter that ended in Mar. 2024 was $0.42.
During the past 12 months, KORU Medical Systems's average Book Value Per Share Growth Rate was -36.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -18.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 18.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of KORU Medical Systems was 67.80% per year. The lowest was -52.50% per year. And the median was 17.80% per year.
KORU Medical Systems's current price is $2.11. Its book value per share for the quarter that ended in Mar. 2024 was $0.42. Hence, today's PB Ratio of KORU Medical Systems is 5.05.
During the past 13 years, the highest P/B Ratio of KORU Medical Systems was 37.58. The lowest was 1.13. And the median was 3.78.
The historical data trend for KORU Medical Systems's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KORU Medical Systems Annual Data | |||||||||||||||||||||
Trend | Feb14 | Feb15 | Feb16 | Feb17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Book Value per Share | Get a 7-Day Free Trial | 0.28 | 0.84 | 0.82 | 0.69 | 0.45 |
KORU Medical Systems Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Book Value per Share | Get a 7-Day Free Trial | 0.65 | 0.62 | 0.60 | 0.45 | 0.42 |
For the Medical Instruments & Supplies subindustry, KORU Medical Systems's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's PB Ratio distribution charts can be found below:
* The bar in red indicates where KORU Medical Systems's PB Ratio falls into.
KORU Medical Systems's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (20.35 | - | 0.00) | / | 45.67 | |
= | 0.45 |
KORU Medical Systems's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (19.12 | - | 0.00) | / | 45.72 | |
= | 0.42 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
KORU Medical Systems (NAS:KRMD) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Thank you for viewing the detailed overview of KORU Medical Systems's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Manko Joseph M. Jr. | 10 percent owner | 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
Kenneth E Miller | officer: Chief Commercial Officer | 26 MOUNTAINVIEW RD, WARREN NJ 07059 |
Edward Wholihan | director | C/O ALLENA PHARMACEUTICALS, INC., ONE NEWTOWN EXECUTIVE PARK SUITE 202, NEWTON MA 02462 |
Linda M Tharby | officer: President and CEO | BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
Robert Cascella | director | C/O HOLOGIC, INC., BEDFORD MA 01730 |
Lafrence Andrew D.c. | officer: Chief Financial Officer | C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070 |
Thomas Edward Adams | officer: Interim CFO | 524 WOODLAND AVENUE, BRIELLE NJ 08730 |
Brian Case | officer: Chief Technology Officer | 424 CYPRUS CIR, LAKE VILLA IL 60046-8629 |
Shahriar Matin | director | 96 TALAMINE COURT, COLORADO SPRINGS CO 80907 |
Donna French | director | 25 SEARSVILLE COURT, HILLSBOROUGH CA 94010 |
Donald B Pettigrew | officer: Pres./Chief Commercial Officer | 7871 ENGEN LOOP, PARK CITY UT 84098 |
Karen Fisher | officer: CFO | 24 CARPENTER ROAD, CHESTER NY 10918 |
Daniel S Goldberger | director | 24 CARPENTER ROAD, CHESTER NY 10918 |
R John Fletcher | director | C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070 |
Horton Freedom, L.p. | 10 percent owner | 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
From GuruFocus
By Business Wire Business Wire • 02-22-2023
By Business Wire Business Wire • 11-10-2022
By Business Wire Business Wire • 11-21-2022
By Business Wire • 07-31-2023
By Business Wire Business Wire • 04-21-2023
By Business Wire Business Wire • 04-18-2022
By Business Wire • 11-07-2023
By Business Wire • 07-27-2023
By GuruFocus Research • 11-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.